Emergency Department Implementation of the i-STAT Alinity Traumatic Brain Injury Whole Blood Test
NCT: NCT07373509 · RECRUITING
Brief Summary
The objective of this study is to identify determinants for implementing the i-STAT Alinity whole blood traumatic brain injury (TBI) test for its Food and Drug Administration (FDA)-indicated use and to evaluate other potential outcomes with clinical implications. The main questions it aims to answer are: 1. Determine the number of patients with non-elevated (i.e., below clinical cutoff) whole blood iSTAT Alinity tests who also receive CT scans. 2. What are the obstacles for using the i-STAT Alinity for its FDA-indicated use
Frequently Asked Questions
What is Emergency Department Implementation of the i-STAT Alinity Traumatic Brain Injury Whole Blood Test?
Emergency Department Implementation of the i-STAT Alinity Traumatic Brain Injury Whole Blood Test is a clinical trial registered under NCT07373509. Current status: RECRUITING.
What is the status of NCT07373509?
The current status of NCT07373509 (Emergency Department Implementation of the i-STAT Alinity Traumatic Brain Injury Whole Blood Test) is: RECRUITING.
When did Emergency Department Implementation of the i-STAT Alinity Traumatic Brain Injury Whole Blood Test start?
Emergency Department Implementation of the i-STAT Alinity Traumatic Brain Injury Whole Blood Test started on 2026-01-13.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.